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ABSTRACT 
 
ALCOHOL CONSUMPTION AND MARIJUANA USE INTERACTION WITH METABOLIC SYNDROME 
AMONG UNITED STATES ADULTS: ANALYSIS OF NHANES 2013-2014. 
By 
 
PIUS AKANDE 
 
APRIL 2018 
 
INTRODUCTION: The relationship between alcohol, marijuana and metabolic syndrome 
remains controversial.  Marijuana has been found to be a commonly used drug among those 
who drink alcohol, yet little is known about the effect of using both substances concurrently 
with metabolic syndrome. With decriminalization of marijuana across different states in the 
United States, it is expected that the prevalence of marijuana use will increase. Therefore, it is 
of utmost importance to understand the adverse impact of these drugs on metabolic 
syndrome.  
AIM: This study aims to understand (a) the relationship between alcohol and marijuana use and 
metabolic syndrome (b) the association between concurrent use of alcohol and marijuana and 
metabolic syndrome, and (c) the statistical interaction of alcohol and marijuana use on 
metabolic syndrome using the National Health and Nutrition Examination Survey data. 
METHODS: A cross-sectional analysis of 2013-2014 National Health and Nutrition Examination 
survey data was conducted. Participants aged ≥20 years were eligible. Metabolic syndrome was 
defined by the International Diabetes Federation criteria. The adjusted odds ratio of metabolic 
syndrome was calculated controlling for variables fitted using stepwise logistic regression 
model selection.   
RESULTS:  After adjusting for age, race, educational level, marital status, poverty, and cigarette 
smoking status; current drinkers showed a significant inverse association with metabolic 
syndrome (aOR, 0.69 95% CI, 0.49-0.99). The odds of metabolic syndrome in concurrent users 
(aOR 0.53 95% CI, 0.28-0.99) was less than the odds among non-concurrent users. Compared 
with young adults, middle-aged and older adults had increased odds of metabolic syndrome.  
DISCUSSION:  This data indicates that alcohol consumption and co-use of alcohol and marijuana 
is associated with a lower prevalence of metabolic syndrome. Longitudinal studies are needed 
to confirm these findings. Notably, age and smoking are significant predictors of metabolic 
syndrome. 
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CHAPTER I – INTRODUCTION 
1.1. Background 
Cardiovascular diseases are the leading cause of death both worldwide and in the 
United States.1,2 The risk factors for these diseases tend to aggregate in individuals, and the 
collective presence of three or more of these factors has been referred to as Insulin resistance 
syndrome or Syndrome X or Metabolic syndrome. 
Metabolic syndrome is a disease entity characterized by central obesity, impaired 
fasting glucose, raised blood pressure, raised triglycerides and reduced high-density lipoprotein 
(HDL) cholesterol.3 It is a heterogeneous cardiovascular risk factor, in that each element of this 
syndrome can be a risk factor independently. Research by Stern, William & Gonzalez-
Villalpando (as cited in IDF consensus statement, 2006) concluded that about a quarter of the 
world’s adult population has metabolic syndrome.4 Compared to people without the syndrome, 
those with metabolic syndrome are twice as likely to die from and thrice more likely to have a 
heart attack or stroke.2   Metabolic syndrome poses an indirect economic burden worldwide in 
that it increases the risk of Type 2 diabetes by fivefold. The annual direct health care cost 
attributed to diabetes worldwide is around 289 billion international dollars (ID), and it is 
estimated the cost will increase to over 300 billion ID by 2025. Addressing this problem is 
therefore of prime concern. Aside the significant risk factors for metabolic syndrome, other 
factors implicated include sedentary lifestyle, use of substances such as cigarette, alcohol, and 
marijuana. 
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Alcohol consumption and illicit drug use, including marijuana among adults Americans is 
a widespread and incessant public health problem with colossal physical, social and economic 
consequences for the nation. In 2015, about 13.6 million adults and 22.2 million aged 12 years 
and older were current users of marijuana and alcohol respectively.4 The role of alcohol and 
marijuana and its effect on metabolic syndrome remain controversial. Studies suggest that 
alcohol consumption is related to metabolic syndrome. Light to moderate consumption of 
alcohol has been found to inversely related with metabolic syndrome, while heavy 
consumption is associated with an increased risk of metabolic syndrome by influencing its 
components.5  
Marijuana remains a commonly used illicit drug among those who drink.6 The swift 
evolution of marijuana policies over the years highlights the need to understand the interaction 
of these two drugs and its adverse metabolic outcomes.7 Past research on the association of 
marijuana on metabolic syndrome has revealed conflicting results.8,9 Numerous relationships 
between independent use of alcohol and marijuana, and risk of metabolic syndrome has been 
established, there remains a gap in research about the effect of co-use of both drugs on 
metabolic syndrome. Also, there have been very little research on the interaction of alcohol and 
marijuana use on metabolic syndrome.   
 
1.2 Research Aims and Hypothesis 
This research will determine the extent to which alcohol and marijuana use contributes 
to the risk of metabolic syndrome among adults in the United States using data from the 
National Health and Nutritional Examination Survey. 
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The overall goals will be to explain the independent and interactive association of 
alcohol and marijuana use and metabolic syndrome. Also, the relationship between concurrent 
use of alcohol and marijuana, and metabolic syndrome will be examined. Gaining more 
knowledge about these association will add to the body of literature and assist in public health 
planning. 
Aim 1: Determine the extent of the relationship between alcohol and marijuana use and 
metabolic syndrome. 
Hypothesis 1: Independent alcohol and marijuana use, compared to nonuse, will be associated 
with metabolic syndrome. 
Aim 2: Determine the association between concurrent use of alcohol and marijuana and 
metabolic syndrome. 
Hypothesis 2: concurrent use, compared to nonuse, will be associated with metabolic syndrome  
Aim 3: Determine the statistical interaction of alcohol and marijuana use on metabolic 
syndrome. 
Hypothesis 3: The effect of Marijuana use on metabolic syndrome is dependent on alcohol use. 
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CHAPTER II – Literature Review 
 
2.1. Alcohol and Metabolic Syndrome 
According to the World Health Organization, alcohol is a psychoactive substance with 
dependent-producing qualities. Harmful use of alcohol is a significant public health concern in 
societies because it is implicated in more than 200 disease conditions. Its consumption is 
associated health problems such as alcohol dependence, noncommunicable diseases, such as 
liver cirrhosis, cardiovascular diseases, and some cancers.10 Alcohol consumption is responsible 
for unintentional and intentional injuries, including those that result from violence, suicides, 
and road traffic accident. 
 Globally, about 13.5 grams of pure alcohol per day is consumed by persons aged 15 
years or older, and harmful use of alcohol is responsible for 3.3 million deaths every year. 
Alcohol consumption is an important long-term risk factor for cardiovascular diseases such as 
hypertension, heart disease, and stroke.  In the United States, it is responsible for 1 in 10 deaths 
among working-age adults aged 20-64 years. In 2010, the economic costs of excessive alcohol 
use were nearly $249 billion which translates to $2.05 per day.10   
Several studies have focused on the impact of alcohol use on the risk of metabolic 
syndrome. Reports are unstable and controversial. Studies have found positive correlations,11 
others have found contrary12 or no correlations between alcohol and metabolic syndrome.13  
Djousse et al., (2004) in a cross-sectional study involving 4510 white participants of the 
National Heart, Lung, and Blood Institute Family Heart Study, examined the association 
between total and beverage-specific alcohol consumption and the prevalence odds of 
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Metabolic Syndrome.  The authors observed  reduced prevalence odds of metabolic syndrome 
across all beverage types: compared with never-drinkers, multivariate-adjusted odds ratios 
(95% confidence interval) of metabolic syndrome were 0.32 (0.14 to 0.73), 0.42 (0.23 to 0.77), 
0.57 (0.30 to 1.09), and 0.56 (0.36 to 0.88) for subjects who consumed >7 drinks/week of wine 
only, beer only, spirits only, and more than one type of beverage, respectively. The writers 
concluded that irrespective of the type of beverage consumed, alcohol remains associated with 
a lower prevalence of Metabolic syndrome.14 
 Sun et al., (2014) examined the association between alcohol consumption and risk of 
metabolic syndrome in a meta-analysis of prospective studies.  The authors analyzed data from 
six prospective studies involving 28,862 participants with 3305 cases of metabolic syndrome 
from different populations (2 studies in Asia, two studies in Europe and 2 in America). 
Compared with nondrinkers, very light drinker was associated with decreased risk of metabolic 
syndrome [pooled relative risk (RR): 0.86, 95% CL: 0.75-0.99] while heavy drinker was 
associated with increased risk of metabolic syndrome (pooled RR 1.84, 95% CI: 1.34-2.52). The 
article concluded that heavy alcohol consumption might be associated with an increased risk of 
metabolic syndrome. They cautioned, however, the fact that measurement of alcohol 
consumption is not standardized could complicate findings among studies.15  
Yokoyama et al., (2007) examined the effect of alcohol consumption on the diagnosis of 
metabolic syndrome in a cross-sectional study of 2,130 Japanese men aged 20 to 65 years. The 
authors assessed excessive alcohol via questionnaire as people who consume more than 20g 
per day, and others were considered as average drinkers. The authors defined metabolic 
syndrome with the modified National Cholesterol Education Program: Adult Treatment Panel III 
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(NCEPATPIII) which require the presence of any three of the five components: central obesity, 
hypertension, hyperlipidemia, decreased high-density lipoprotein cholesterol, and raised fasting 
blood glucose for the diagnosis of metabolic syndrome. Prevalence of metabolic syndrome was 
significantly higher in excessive drinkers (22.2%) than average drinkers (13.9%, chi2 = 18.0, 
P<0.0001). Yokoyama et al. concluded heavy alcohol consumption might be a factor worsening 
metabolic syndrome.11 
Santos, Ebrahim & Barros, (2006) conducted a cross-sectional study to determine the 
association of physical activity, sleeping hours, alcohol intake and smoking and metabolic 
syndromes. The authors examined self-reported social, demographic, personal and family 
medical histories and behavioral characteristics of 832 men and 1332 women aged 18—92 
years. Alcohol consumption was assessed based on the type of alcoholic beverage and the 
amount in grams consumed, and metabolic syndrome was defined using the NCEP/ATP III 
criteria. After adjusting for age, education, physical activity, and smoking, there was no 
statistically significant relationship between ethanol intake and metabolic syndrome (aOR 1.56, 
95% CI, 0.82, 2.96).12 
Yokoyama, (2011) in another cross-sectional study involving 371 non-diabetic Japanese 
workers examined whether alcoholic beverages could be the remedies for insulin resistance 
that plays a pivotal role in the development of Metabolic syndrome. Yokoyama looked at the 
correlation between levels of ethanol consumption and insulin resistance. He assessed insulin 
resistance by using the homeostatic model assessment (HOMA). Yokoyama found that ethanol 
consumption was inversely correlated with insulin resistance levels. He noted, however, that 
such beneficial effects may not apply to subjects with obesity. Yokoyama also noted various 
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limitations due to the experimental design, including lack of information on the integrating 
amount of ethanol consumption, types of alcoholic beverage and precise evaluation of liver and 
pancreatic cirrhosis which can both play a role in insulin resistance.16  
(Castelli et al., 1977; Macmahon, 1987 & Langer et al., 1992), revealed (as cited in Frujita 
& Takei, 2001) that regular, light to moderate consumption of alcohol could reduce the risk of 
coronary heart disease. The authors found that the beneficial effect of light to moderate 
alcohol consumption can be explained by several factors, including increases in the high-density 
lipoprotein cholesterol, while detrimental impacts of heavy alcohol use are due to an increase 
in plasma triacylglycerol and raised blood pressure.4 
 
2.2. Alcohol and Components of Metabolic Syndrome 
Several studies have shown that that alcohol consumption has independent effects on 
the components of metabolic syndrome. Yoon et al., (2004) examined the relationship between 
alcohol and the metabolic syndrome in a secondary analysis of 3597 men and 4365 women who 
had participated in the Korean National Health and Nutrition Examination Survey. The adjusted 
odds ratio for the metabolic syndrome in the group consuming < 15g of alcohol /day was 0.71 
(95% CI: 0.53, 0.95) in men and 0.80 (95% CI: 0.65, 0.98) in women. Also, heavy alcohol 
consumption (≥ 30g/d) was associated with significantly higher odds ratios for high blood 
pressure and high triacylglycerol in men, and high fasting blood glucose and high triacylglycerol 
on women.17  
Kim et al., (2017) evaluated the relationship between alcohol consumption and 
Metabolic syndrome components in a community-based cohort of 10,037 subjects. The authors 
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found that among men, compared to non-drinker, consumption of >30 g/day showed 
significant association with high blood pressure (OR 1.63 95% CI: 1.36-1.94), high fasting 
glucose (OR 1.88 95% CI: 1.40-2.51), hypertriglyceridemia (OR 1.77 95% CI: 1.44-2.04) and 
inverse association with low HDL cholesterol (OR 0.30 95% CI: 0.25-0.36). The study also found 
a similar association between light and moderate drinkers. Among women, the authors found 
that heavy drinkers (>30 g/day) are likely to have high fasting glucose (OR 3.50 95% CI: 1.41-
8.71) compared to non-drinkers. The authors concluded that daily alcohol consumption of 
>5g/day might contribute to abnormalities of Metabolic syndrome including high glucose and 
blood pressure, hypertriglyceridemia, and low HDL cholesterol.18 
Most prospective cohorts reviewed revealed that risk of obesity/weight gain, an 
essential component of IDF definition metabolic syndrome depends on the amount and type of 
alcoholic beverage consumed. Schütze et al., (2009) in a prospective European study, examined 
associations between beer consumption and waist circumference (WC). In a secondary analysis 
of 7876 men and 12749 women within the European Prospective Investigation into Cancer and 
Nutrition (EPIC)-Potsdam study. Men who consumed 1000ml of beer/day had 17% higher WC 
compared with light drinkers (≥ 250 to <500ml/day). In women, there was a significant inverse 
relationship between beer-abstaining women and WC gain (odds ratio: 0.88 95% CI: 0.81, 0.96) 
compared to very-light drinking women. However, after adjusting for concurrent body weight 
and hip circumference, a non-significant association was observed.19 
Maclnnis et al., (2013) evaluated the predictors of increased adiposity for different 
measures of adiposity in a prospective cohort study of 5879 Australian-born participants, aged 
40 to 69 years with data collected at baseline (1990—1994) and wave 2 (2003—2007). Subjects 
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who consumed low to moderate amounts of alcohol were less likely to have elevated waist 
circumference at wave 2. The authors concluded that limiting alcohol intake could be one of the 
promising ways of preventing obesity in adults.20 
 In another prospective study by Rissanen et al., (1991), 12,669 adults were examined 
twice with a median interval of 5.7 years. The authors found that heavy drinking was associated 
with substantial weight gain in women.21  
 
2.3. Marijuana  
Marijuana consists of over 421 components and 60 pharmacologically active 
cannabinoids. The two most well-known and understood cannabinoids are delta9-
tetrahydrocannabinol (THC) and cannabidiol (CBD). Other components are not fully 
understood, and their mental and physical effects are unknown.22 
Marijuana also known as cannabis act via two receptors; CB1 and CB2. CB1 is mainly 
found in the brain and the spinal cord while CB2 receptors are predominately expressed in the 
peripheral tissues of cells in the immune system, hematopoietic system, and reticuloendothelial 
system. Moreover, acts majorly on the brain and spinal cord.22  
Marijuana has many documented toxic effects including acute effects like; impairment 
of cognitive and psychomotor function.  
Chronic effect of cannabis use includes cannabis dependence syndrome, exacerbation of 
symptoms in schizophrenic patients, epithelial injury of the respiratory system, and increased 
prevalence of chronic bronchitis.23 
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2.4 Marijuana Prevalence 
According to the Center for Disease Control (CDC), marijuana is the most commonly 
used illegal drug in the united states with about 22.2 million users every month,3  and it has a 
very high index for addiction. Research shows that 1 in every ten marijuana users will become 
addicted.24 Worldwide, it is the most used illicit drug, about 2.5% of the world population 
consume cannabis which is higher than 0.2% consuming cocaine and 0.2% consuming opiates.22 
With the decriminalization and legalization of marijuana, the significant public health 
concern is that its legalization will increase its use. Currently, 23 states and territories in the 
USA have legalized medical marijuana use, and recreational use is now legal in four states.25 
2.5. Marijuana and Metabolic Syndrome 
Evidence from studies suggests that marijuana use influences the cardiovascular 
physiology. It increases heart, systolic and diastolic blood pressures; these actions increase the 
oxygen demand of the myocardium.7 
The risk of cardiovascular disease increases by about five times for users and more for 
users with pre-existing conditions.26 Metabolic syndrome is a well-known major risk factor for 
cardiovascular diseases; therefore, it is relevant to review marijuana’s effect on the syndrome.  
Franz & Frishman 2016, evaluated recreational marijuana and cardiovascular disease, 
the authors found that smoking marijuana increases the risk of myocardial infarction by a factor 
of 4.8 for the 60 minutes after marijuana use. Franz and Frishman recommended against the 
recreational marijuana use, especially in individuals with a history of coronary artery diseases.7  
Vidot et al., (2015) used data from a representative study of US adults aged 20- to 59-
years, the National Health and Nutrition Examination Survey (NHANES), to explore the 
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relationship between marijuana use and metabolic syndrome. The investigators found that 
current marijuana users had lower odds of metabolic syndrome than never users (adjusted 
odds ratio [AOR] 0.69; 95%confidence intervals [CI], 0.47-1.00; P =. 05). Besides, among 
emerging adults (20-30 years old), current marijuana users were 54% less likely than never 
users to present with metabolic syndrome. Compared with never users, past (AOR 0.61; 95% CI, 
0.40-0.91) and current (AOR 0.49; 95% CI, 0.25-0.97) middle -age marijuana users were less 
likely to develop metabolic syndrome.27 
Thompson and Hay, (2015) in a cross-sectional study examined the relationship of 
metabolic risk factors and marijuana use in U.S. adults using the data from the continuous 
National Health and Nutrition Examination Survey (NHANES). Using the data on from 6281 
participants and computing the ordinary least squares (OLS) models, revealed that fasting 
insulin, insulin resistance, body mass index, and waist circumference were all significantly lower 
in current marijuana users compared to lifetime non-users. To test the reliability of the model, 
the researchers substituted marijuana use with alcohol use as the risk factor of interest; the 
result was like the estimates of the effect of marijuana use. The authors concluded that while 
current users of marijuana may less likely develop metabolic syndrome, OLS regression might 
not be a reliable model to examine the association.8 
Muniyappa et al., (2013) also examined the metabolic effect of chronic cannabis 
smoking. In the cross-sectional case-control study, 18 men and 12 women aged 27 ± 8 years 
were matched for sex, age, body mass index and ethnicity with 30 controls. The authors found 
that chronic cannabis smoking was associated with visceral adiposity (18 ± 9 vs. 12 ± 5%; 
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p=0.004). lower HDL cholesterol (49 ± 14 vs. 55 ± 13 mg/dL; p= 0.02), and adipose tissue insulin 
resistance,28 all components of metabolic syndrome. 
Le Strat and Le Foll, (2011) analyzed data from 2 cross-sectional epidemiologic studies of 
US adults aged 18 years or older, the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC; 2001–2002) and the National Comorbidity Survey–Replication (NCS-R; 
2001–2003). The specific aim was to estimate the prevalence of obesity as a function of 
cannabis use. The authors found that adjusted prevalence of obesity in the NESARC and the 
NCS-R were 22.0% and 25.3%, respectively among subject reporting no use of cannabis in the 
past 12 months and 14.3% and 17.2%, respectively, among participants reporting the use of 
cannabis at least three days per week. Additionally, after adjusting for sex and age, the use of 
cannabis was associated with body mass index differences in both samples. The authors 
concluded that the prevalence of obesity is lower in cannabis users than in nonusers.29 
In a recent study, Yankey et al., (2017) evaluated the relationship between years of self-
reported marijuana use and metabolic syndrome using the National Health and Nutrition 
Examination Survey (NHANES) 2011-2012. Surprisingly, irrespective of the criteria used, the 
adjusted odds ratio (aOR) for having metabolic syndrome with each increase in year of 
marijuana use. The aOR was 1.05 (95% CI: 1.02, 1.08), 1.08 (95% CI: 1.04, 1.13) and 1.05 (95% 
CI: 1.04, 1.13) for National Cholesterol Education Program Adult Treatment Panel III (ATP III), 
International Diabetes Federation (IDF), and World Health Organization (WHO) respectively. 
Furthermore, the authors found a significant association between each year of marijuana use 
and components of metabolic syndrome (hypertension and abdominal obesity). The adjusted 
OR of Hypertension was 1.05 (95% CI: 1.01, 1.09) for WHO criteria and 1.08 (95% CI: 1.03, 1.12) 
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using EGIR. Irrespective of the criteria, each year of marijuana use was associated with 
increased odds for abdominal obesity: aOR 1.06 (95% CI: 1.00, 1.11) (ATP III), 1.09 (95% CI: 1.05, 
1.14) (EGIR), and 1.07 (95% CI: 1.01, 1.13) (IDF). The authors concluded that recreational 
marijuana use might be detrimental to cardiovascular health.30 
 
2.6. Alcohol and Marijuana co-use and Metabolic Syndrome. 
The decriminalization and legalization of marijuana coupled with the consumption of 
alcohol in significant amounts raise a public health concern. Pacula and Sevigny, (2014) argued 
that marijuana liberalization policies could lead to increases in both alcohol and marijuana use, 
hence the need to fully understand the association between these two substances, especially 
about their public health consequences.31 
Subbaraman & Kerr, (2015) examined the differences in demographics, alcohol-related 
social consequences, harms to self, and drunk driving across simultaneous, concurrent and 
alcohol-only groups. The authors conducted a secondary analysis of data from the 2005 and 
2010 National Alcohol Survey involving 4,522 females, and 4,104 males. The authors found that 
individuals who used both cannabis and alcohol tend to use them at the same time 
(simultaneous use). Also, compared with alcohol only use, the odds of drunk driving, social 
consequences, and harms to self is two times among simultaneous users.5 
Alcohol consumption and marijuana use have independently been associated with 
metabolic syndrome. However, little or no study has examined the combined effects of alcohol 
consumption and marijuana use on metabolic syndrome. Findings from the literature reviewed 
suggest that interaction of these drugs may result in detrimental effect. This thesis will also 
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examine the interaction of alcohol consumption and marijuana use on metabolic syndrome. 
Understanding the interaction between alcohol and marijuana and the risk of metabolic 
syndrome will add to the body of knowledge, assist in policy initiatives and the implementation 
of effective preventive strategies against cardiovascular diseases. 
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CHAPTER III – METHODOLOGY  
 
3.1. Study Design 
This research will analyze data from the National Health and Nutrition Examination 
Survey (NHANES). NHANES is a scheme of studies that assess the health and nutritional status 
of adults and children in the United States. It is under the oversight of National Center for 
Health Statistics (NCHS), a division in the Centers for Disease Control and Prevention with the 
responsibility of producing vital and health statistics for the country. 
The program started over five decades ago, and it is an ongoing revolving survey that 
addresses the health and nutritional topics of different populations. The survey examines about 
5,000 nationally representative sample annually, located in various counties across the nation, 
fifteen of which are visited. 
The survey has two components; Using Computer-Assisted Personal Interview 
Technology (CAPI), for conducting an initial in-person interview in the participant’s home, and it 
includes; demographic, socioeconomic, dietary health-related questions. The examination 
component which consists of medical, dental, physiological measurements, and laboratory tests 
conducted by highly trained medical personnel in specifically designed mobile examination 
centers (MEC). This survey collects information on prevalence of chronic conditions in the 
population. Also, it provides an estimate of previously undiagnosed conditions as well as 
aspects of a person’s lifestyle, heredity, constitution, or environment that may increase the 
chances of developing a specific disease 
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Data of this survey are used in epidemiological studies and health sciences research, 
which help build effective public health initiative and policy. Also, information from the survey 
helps the public health professionals determine disease prevalence and predisposing factors, 
assess nutritional status and its association to health promotion and prevention. 
Eligibility criteria: adults ≥ 20 years who were involved in the 2012-2013 NHANES were 
included in the study. 
Variables of Interest 
Dependent Variable 
Metabolic Syndrome 
Metabolic Syndrome was defined using the International Diabetes Federation (IDF) 
criteria. These criteria were used because central obesity which is the driver for most 
cardiovascular diseases was used as the primary criterion. It is also a universally accessible, 
diagnostic tool that addresses both clinical and research needs by providing a comprehensive 
list of criteria including ethnic specific cut-off points that should be included in research into the 
metabolic syndrome. 
IDF defined Metabolic Syndrome as the presence of: 
Central Obesity: defined as waist circumference with ethnicity-specific values; ≥ 102 cm 
(white males) or ≥ 88 cm (white females); ≥ 94 cm (black males) or ≥ 80 cm (black females); ≥ 
94cm (Mexican American/Multiracial males) or ≥ 80 cm (Mexican American/Multiracial 
females). The IDF recommends ethnic group-specific cut-points should be used for people of 
the same ethnic group wherever they are found. Thus, the criteria recommended for central 
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Americans was also be used in Mexican Americans, as would those for central Americans males 
and females regardless of place and country of residence.  
Plus any two of the following: raised triglycerides ≥ 150mg/dL or on treatment for this 
lipid abnormality; reduced HDL cholesterol <40 mg/dL in males and < 50mg/dL in females or on 
treatment for this lipid abnormality; raised blood pressure systolic blood pressure ≥ 130 or 
diastolic blood pressure ≥ 85 mm Hg or on treatment for previously diagnosed hypertension; 
raised fasting plasma glucose (FPG) ≥ 100mg/dL, or previously diagnosed type 2 diabetes.  
Information about laboratory and clinical procedures are well-documented in the 
NHANES manual.32 
Independent Variables 
Main independent variables were marijuana and alcohol use. 
Marijuana Use 
Marijuana use was categorized into current marijuana users (those who have used 
marijuana before and at least ≥ one day in the last 30days), and never marijuana users (never 
used marijuana). The definition was based on the following questions: 1.) Ever used marijuana 
or hashish? 2.) During the past 30 days, on how many days did you use marijuana or hashish?  
Alcohol Use 
Alcohol use was categorized into nondrinkers (have not had any drink in the past 12 
months and not up to 12 drinks in their entire lifetime), current drinkers (had at least 12 drinks 
in the past year and had a drink at least ≥ one day in the last 30 days). According to the National 
Institute on Alcohol Abuse and Alcoholism, current drinkers were further divided into 
low/moderate drinkers (men: up to 2 drinks per day, women: up to a drink per day), and heavy 
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drinker (men: 4 or more drinks on any day, women: 3 or more drinks on any day).33 Alcohol use 
definition was based on the following questions; 1.) In your entire life, have you had at least 12 
drinks of any alcoholic beverage? 2.) In any one year, have you had at least 12 drinks of any 
type of alcoholic beverage. 3.) In the past 12 months, on those days that you drank alcoholic 
beverages, on the average, how many drinks did you have? 4.) How many days per week, per 
month, or per year did you drink alcohol? 
 
Concurrent Use 
Based on the current drinking and marijuana status, a new indicator variable addressing 
concurrent use was created. Concurrent users were categorized as Yes: (if classified as both 
current drinker and current marijuana user) and No (classified as either a current drinker or 
current marijuana user). 
Other Independent Variables 
Age  
Reported as the age in years at the time of participation. Participants were evenly 
distributed  across three age categories young adults (20-35) years, middle-aged adults (36-55) 
years and older aged adults (> 55) years 
Race 
Categorized into White, African American, Hispanics, and Other Race/Multi-racial 
Gender 
Gender of the participant at the time of screening. Grouped into male and female based 
on self-reported data.  
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Educational level 
Categorized into ≤ High School and > High school. 
Family to income ratio (PIR) 
PIR denotes the ratio of the family’s income to the poverty threshold. PIR was used in 
this study as a measure of socioeconomic status. Based on the standard recommended by 
United States Poverty Guideline 2018, participants’ PIR was classified into three categories; < 
1.00, 1.00 - 4.00, and > 4.00. 
Marital status 
For this study, participant’s marital status is categorized as Married and Others. 
Physical Activity 
Physical activity was categorized into two groups: physically active and physically 
inactive. Participants were allocated to this group based on their response to the following 
questions from the NHANES questionnaire: “In a typical week do you do any vigorous-intensity 
sports, fitness, or recreational activities that cause large increases in breathing or heart rate like 
running or basketball for at least 10 minutes continuously?” or “ In a typical week do you do 
any moderate-intensity sports, fitness, or recreational activities that cause a small increase in 
breathing or heart rate such as brisk walking, bicycling, swimming, or volleyball for at least 10 
minutes continuously?” participants that responded ‘yes’ to either of the aforementioned 
questions were classified as physically active while those that responded ‘no’ were allocated to 
the physically inactive group. 
Cigarette Smoking 
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Current cigarettes smokers: Participants who reported they had smoked at least 100 
cigarettes in their lifetime, and still smoke on some days or every day. Past smokers: 
participants who have smoked at least 100 cigarettes in their lifetime but do not currently 
smoke. Never smoker: those who have never smoked cigarettes. 
 
3.2. Statistical Analysis 
All analyses were performed using SAS 9.4 (Statistical Analysis System, Cary, NC, USA). In 
2013-2014, NHANES included 14,332 persons selected from 30 different survey locations to 
participate in the study. Of those selected, 10,175 and 9,813 completed the interview and 
examination respectively. For this thesis, the sample size was 2,142 (20 years and older).  
Descriptive statistics were conducted for all participant characteristics including age, 
gender, race, marital status, education, and family to income ratio (PIR).  Bivariate analyses 
were conducted using Chi-Square Test for categorical variables and the Wilcoxon Rank sum test 
for continuous variables.  
Multivariable logistic regression models were constructed to explore the effects of the 
primary independent variables on metabolic syndrome. The logistic regression results are 
reported as odd ratios (OR) and 95% confidence interval (CI). A Stepwise selection method was 
used to identify the significant predictors of metabolic syndrome. A significance level of 0.3 is 
required to allow a variable into the model (SLENTRY= 0.3), while a significance level of 0.35 is 
required for a variable to stay in the model (SLSTAY= 0.35). The final model included variables 
fitted by stepwise selection and a priori, potential confounders identified by the bivariate 
analysis. Overall, three models were fitted – alcohol consumption, marijuana use, & concurrent 
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use. The statistical interaction between alcohol consumption and marijuana use was also 
assessed using their product term, with the level of significance determined using the likelihood 
ratio test. A two-sided P value < 0.05 was considered statistically significant for all analyses. 
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CHAPTER IV – RESULTS 
4.1. Descriptive Statistics 
Overall, 2,239 participants aged 20 years and older were included in this analysis. The 
demographic and other characteristics of participants who self-reported for alcohol and 
marijuana use were similar. Participants with missing data on the variable of interest were 
excluded. Most respondents were between 35 and 55 years, and nearly half of the participants 
who self-reported for alcohol and marijuana were whites (34%-41.6%). Majority attained above 
high school education (59% – 62.6%), are physically inactive (62% – 63.2%) and met the IDF 
definition for central obesity (67%).  
Alcohol Use Characteristics 
Of the participants, 930 (77.2%) were current drinkers, and 275 (22%) were non-
drinkers. 55.5% are males, and 45.5 % are females. Current drinkers are mostly young adults 
(37.9%) and middle-aged adults (41.6%). White Americans consume alcohol at the highest rate 
among major ethnic groups (45.4%), followed by blacks (21.6%), Hispanics (20.4%), and other 
races (12.6%). Almost have of current drinkers had above high school education (65.0%), are 
physically inactive (60.9%) and are current smokers (26.8%).  (Table 1.1). 
The Proportion of Central obesity among current drinkers was 57.8% compared to 
70.8% among non-drinkers (P < 0.01). Prevalence of raised fasting blood glucose, raised systolic 
blood pressure, and low HDL cholesterol was similar in the participants who were current and 
non-drinkers.  
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Marijuana Use Characteristics 
There were 223(23.8%) current users and 714(76.2%) never users of marijuana. Majority of 
current users are young (64.6%). Marijuana use was highest among whites (46.6%), followed by 
blacks (29.6%), Hispanics (14.8%) and other races (9%). Males are nearly twice as likely (62.8%) 
to use marijuana as females (37.2%). Current marijuana use is also more common among 
participants who are not legally married (78%), had above high school education (52%), 
physically inactive (51.1%) and current smokers (56.5%). 
Participants who reported current use of marijuana have significantly lower body waist 
circumference (median 89.6 vs 95.5 cm, P = < 0.01), fasting plasma glucose (median 95.0 vs 97 
mg/dl, P = < 0.01), and diastolic blood pressure (median 68 vs 72 mmHg, P = <0.01) compared 
to those who never smoked marijuana. 
Metabolic Syndrome 
Metabolic syndrome prevalence among participants using International Diabetes 
Federation (IDF) criteria was 29.2%. A Majority were 36 years and older. Prevalence of 
metabolic syndrome was 24.1%, 17.7%, and 13.6%, among current drinkers, current marijuana 
users, and concurrent users respectively. 
 
4.2. Result of Bivariate Analysis 
Alcohol and Participant’s characteristics 
Results revealed a statistically significant difference between alcohol and each of the 
participant’s characteristics (age, gender, race, education, family to income ratio, physical 
activity, smoking- P < 0.01 for all).  There was a statistically significant difference between 
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alcohol use and body waist circumference (P < 0.01), HDL cholesterol (P < 0.01). There was no 
significant difference observed between alcohol use and fasting plasma glucose, triglyceride 
level, systolic and diastolic blood pressure (Table 1.1). 
 Marijuana and Participant’s characteristics (Table 1.2) 
Furthermore, a statistically significant difference was observed between marijuana use 
and each of the following participant’s characteristics (age, gender, race, marital status, family 
to income ratio, physical activity, education and cigarette smoking- P < 0.01 for all). A similar 
result was found between marijuana use and some components of metabolic (body waist 
circumference [P < 0.01] and fasting plasma glucose [P < 0.01]). 
Metabolic Syndrome and Participant’s characteristics (Table 1.3) 
The Chi-square test of association between metabolic syndrome and each of the 
participant’s characteristics (age group, race, education, marital status, family to income ratio, 
and cigarette smoking- P < 0.01 for all) found a statistically significant difference between the 
variables. There was a statistically significant difference between metabolic syndrome and each 
of the two primary independent variables (alcohol and marijuana use, P = 0.02).  
4.3. Result of Multivariate Analysis 
In the unadjusted analysis, current drinkers were less likely to have metabolic syndrome 
compared to non-drinkers (odds ratio [OR], 0.69 95% confidence interval [CI], 0.51-0.94). The 
analysis also revealed similar associations for both current marijuana users and concurrent 
users, with OR, 0.59 95% CI, 0.40-0.86 and OR, 0.44 95% CI, 0.26-0.73 respectively. The odds of 
metabolic syndrome were lower participants that consume low/moderate alcohol compared to 
non-drinkers OR, 0.70 95% CI, 0.49, 0.99 (Table 3.1).  
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Table 2.1, 2.2, and 2.3 give a summary of the stepwise logistic regression model 
selection. After adjusting for age, race, educational level, marital status, poverty, and cigarette 
smoking status; current drinkers showed a significant inverse association with metabolic 
syndrome (adjusted odds ratio [aOR], 0.69 95% confidence interval [CI], 0.49-0.99). In the same 
multivariable model, compared with participants aged 20-35 years, adults between 36 and 55 
years (aOR, 2.57 95% CI, 1.80-3.68) and above 55 years (aOR, 3.36 95% CI, 2.26-4.99) had higher 
odds of metabolic syndrome. Participants who are past smokers had more odds developing 
metabolic syndrome compared to non-smokers. The odds of metabolic syndrome among 
current marijuana users was lower compared to never users, although this association was not 
significant (aOR, 0.62 95% CI,0.38, 1.01).  
Similarly, the odds of Metabolic syndrome among concurrent users was 0.53 times the 
odds of metabolic syndrome among non-concurrent users (95% CI, 0.28-0.99). In both 
marijuana and concurrent model, being 36 years and older was significantly associated with 
increased odds of metabolic syndrome (Table 3.2). Test for statistical interaction between 
alcohol consumption and marijuana use revealed no statistically significant result, and thus the 
product term was not included in the model. 
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CHAPTER V – Discussion 
5.1. Discussion 
The purpose of this thesis was to evaluate alcohol and marijuana use interaction on 
metabolic syndrome among United States adults.  Marijuana remains a commonly used illicit 
drug among those who drink, coupled with the swift evolution of marijuana policies over the 
years, there a need to understand the interaction of these two drugs and its adverse metabolic 
outcomes.  
This study was conducted by using NHANES data, a survey that examines the nationally 
representative sample of about 5,000 persons per year. The survey collects data on the 
prevalence of chronic conditions in the population as well as information on aspects of a 
person’s lifestyle, heredity, constitution, or environment that may increase the chances of 
developing a specific disease. The survey also employed the use of Computer-Assisted Personal 
Interview Technology (CAPI), this allows for clarification and ascertainment of responses. 
Overall, results from this study suggest that current drinkers, current marijuana users, 
and concurrent users were associated with decreased odds of metabolic syndrome. Adjusting 
for age group, race, educational level, marital status, cigarette smoking, and family to income 
ratio; the negative association remained significant with a notable exception for current 
marijuana users. The analysis also found that among current drinkers, those who consumed low 
to moderate proportion of alcohol have lower odds of metabolic syndrome. Participants who 
were 36 years and above were consistently associated with increased odds of metabolic 
syndrome in all three models.  
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Most researchers have focused on the independent relationship of alcohol and 
marijuana use on metabolic syndrome. This thesis is probably the first study till date to examine 
the association between concurrent alcohol/marijuana use and its effect on metabolic 
syndrome. Although, this analysis observed an inverse association between concurrent use and 
metabolic syndrome (aOR, 0.53 95%, 0.28-0.99), still, cautious interpretation of this result is 
needed.  This observed association could be because of how concurrent use was assessed. It is 
important to note that, questions relating to the concurrent use of alcohol and marijuana were 
not directly asked in the NHANES data, and therefore the assessment of concurrent use could 
be biased. It is imperative to conduct further longitudinal studies to confirm if the observed 
association is indeed true.  
The observed inverse association between alcohol use and metabolic syndrome is 
similar to findings from previous studies. Djousse et al., (2004) cross-sectional survey of 
participants of the National Heart, Lung, and Blood Institute Family Heart Study reported 
reduced prevalence odds of metabolic syndrome among alcohol users across all beverage 
types: OR, 95% -- 0.32 (0.14 to 0.73), 0.42 (0.23 to 0.77), 0.57 (0.30 to 1.09), and 0.56 (0.36 to 
0.88) for subjects who consumed more than 7 drinks/week of wine only, beer only, spirits only, 
and more than one type of beverage, respectively.14 The result of this study is not comparable 
to this present study because the authors computed beverage-specific alcohol concentrations, 
and the reported association was not consistent across all beverage groups. 
This thesis also found that low/moderate intake of alcohol is associated with lower odds 
of metabolic syndrome. Earlier studies have also reported similar association. A prior meta-
analysis of six prospective studies in 2014 including 28,862 participants found that very light 
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drinkers have a decreased risk of metabolic syndrome (Pooled RR: 0.86, 95% CL: 0.75-0.99).15 
The research was more superior because the authors conducted a meta-analysis of prospective 
studies with no evidence of heterogenicity or publication bias between the very light and heavy 
alcohol groups. However, non-standardized methods for assessing alcohol consumption noted 
in the study could complicate interpretation of findings among studies. On the other hand, 
people that consume alcohol in low to moderate proportion usually opt for wine instead of 
beer and spirit. It is plausible to say that the observed inverse association may be due to other 
substances found in wine rather than the ethanol itself.  
Also, studies have also found conflicting results on whether alcohol use has a protective 
or detrimental effect on metabolic syndrome. Alcohol has a variable effect on components of 
metabolic syndrome. Freiberg et al., (2003) in a cross-sectional analysis on data from 8,125 
participants from the Third National Health and Nutrition Examination Survey reported that 
alcohol use was significantly and inversely associated with the prevalence of the following three 
components of the metabolic syndrome: low serum HDL cholesterol, elevated serum 
triglycerides, high waist circumference, as well as hyperinsulinemia (P < 0.05 for all).  Thus, the 
inverse relationship observed may differ based on the metabolic profile of the group being 
studied. 
Notably, in all the models constructed, being 36 years and older have higher odds of 
metabolic syndrome, and this was consistent with previous studies that reported that 
prevalence of metabolic syndrome increases with age. 34 A previous cross-sectional survey in 
2012 reported age might influence the relationship between alcohol and metabolic syndrome.35 
In all the models constructed for this study, compared to young adults aged 20-35 years, 
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participants between 36-55 years are over two times likely to have metabolic syndrome and 
those >55 years are over three times more likely to develop the syndrome. It will be imperative 
to understand age-specific relationship between alcohol, marijuana, and metabolic syndrome. 
Another finding from this research indicates that past smokers have higher odds of 
metabolic syndrome. A similar association was observed in previous studies.36 A 2015 study 
reported that former smokers had a higher risk of metabolic syndrome compared to light 
smokers (pooled RR 1.19, 95% CI: 1.00–1.42).37 These findings could be because smoking is 
strongly associated with obesity, a significant determinant in the IDF definition used for this 
study, and higher odds of metabolic syndrome further support the hypothesis that smoking has 
a peripheral metabolic effect in the body. Smokers are likely to have reduced calorific intake, 
which translates to less absorption and storage of fats in adipose tissues. The cessation of 
smoking reverses this process.37  
5.2. Study Limitations and next steps 
Despite apparent strength of using a nationally representative survey for this analysis, 
this study is subject to limitations. Firstly, the NHANES is cross-sectional; no casual inferences 
can be made from these data. This design cannot establish temporality because information 
about whether the alcohol or marijuana use preceded the development of metabolic syndrome 
is not available. The possibility of reverse causality bias cannot be ruled out. More detailed 
longitudinal studies are required to confirm these findings. Secondly, alcohol and marijuana use 
were also accessed via self-report data which are subject to reporting bias. There’s no way to 
ensure that respondents gave accurate answers to questions or just gave a socially desirable 
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response. Biochemical verification may be necessary for objective assessment of these 
responses.  
5.3. Conclusion 
The result of this study suggests that there an inverse relationship between alcohol, 
concurrent alcohol & marijuana use, and metabolic syndrome. However, interpretation should 
be made with caution.  With the evolving climate of decriminalization of marijuana and limited 
research on its potential health effects, policymakers, especially at the state level should 
understand this lack of knowledge is a notable barrier not only to scientific understanding but 
also to the improvement of public policy and public health of the populace.  
The public should be made aware of the role of increasing age and smoking as 
important predictors of metabolic syndrome and the need to institute lifestyle modifications in 
high-risk groups. 
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Table 1.1   Participants Characteristics stratified by Alcohol Use 
 Alcohol Use Total P-value 
 
Demographics 
Current Drinker 
N (%) = 930 (77.2) 
Non-Drinker 
N (%) = 275 (22.8) 
 
1205 
- 
Age 
Median (IQR) 
   20-35 
   36-55 
    >55 
 
41.0 (29.0-53.0) 
352 (37.9) 
387 (41.6) 
191 (20.5) 
 
47.0 (32.0-58.0) 
    81 (29.5) 
  102 (37.1) 
    92 (33.4) 
 
45.0 (33.0-57.0) 
433 (35.9) 
489 (40.6) 
283 (23.5) 
 
 <0.01 w 
<0.01c 
Gender 
   Female 
   Male 
 
  414 (44.5) 
  516 (55.5) 
 
197 (71.6) 
78 (28.4) 
 
  611 (50.7) 
  594 (49.3) 
<0.01c 
Race 
   Hispanic 
   White 
   African- American 
   Other Race/Multi-racial 
 
190 (20.4) 
422 (45.4) 
201 (21.6) 
117 (12.6) 
 
70 (25.5) 
76 (27.6) 
54 (19.6) 
75 (27.3) 
 
260 (21.6) 
498 (41.3) 
255 (21.2) 
192 (15.9) 
<0.01c 
 
Education 
   ≤ High School  
   > High School 
 
325 (35.0) 
604 (65.0) 
 
125 (45.6) 
149 (54.4) 
 
 450 (37.4) 
753 (62.6) 
<0.01c  
Marital Status 
   Married 
   Others 
 
468 (50.3) 
462 (49.7) 
 
159 (57.8) 
116 (42.2) 
 
627 (52.0) 
578 (48.0) 
0.03c 
Poverty to Income Ratio 
Median (IQR) 
   <1.00 
   ≥1.00-4.00 
   >4.00 
 
2.7 (1.2-4.9) 
219 (23.6) 
399 (42.9) 
312 (33.5) 
 
1.64 (0.9-3.3) 
100 (36.4) 
135 (49.1) 
  40 (14.6) 
 
2.1 (1.0-4.2) 
319 (26.5) 
534 (44.3) 
352 (29.2) 
 
<0.01 w 
<0.01 C 
 
Physical Activity 
   Active 
   Inactive 
 
364 (39.1) 
566 (60.9) 
 
  79 (28.7) 
196 (71.3) 
 
443 (36.8) 
762 (63.2) 
<0.01c 
 
Cigarette Use 
   Current Smoker 
   Past Smoker 
   Non-smoker 
 
 249 (26.8) 
199 (21.4) 
482 (51.8) 
 
19 (6.9) 
16 (5.8) 
240 (87.3) 
 
268 (22.2) 
215 (17.8) 
722 (59.9) 
<0.01c 
 
Clinical Information 
Body waist circumference, cm 
   Median (IQR) 
   Central Obesity 
   Normal  
 
97.0 (91.0-105.0) 
530 (57.8) 
387 (42.2) 
 
95.5 (84.4-108.0) 
187 (70.8) 
  77 (29.2) 
 
97.0 (86.0-108.0) 
717 (60.7) 
464 (39.3) 
 
0.21 
<0.01c 
Fasting plasma glucose, mg/dl 
   Median (IQR) 
   < 100 
   ≥ 100 
 
95.2 (84.8-106.6) 
523 (58.0) 
379 (42.0) 
 
99.0 (91.0-107.0) 
148 (55.4) 
119 (44.6) 
 
98.0 (92.0-108.0) 
671 (57.4) 
498 (42.6) 
 
0.20w 
0.46c 
Blood Pressure, mmHg, 
   Systolic blood pressure 
   Median (IQR) 
   < 130 
   ≥ 130 
   Diastolic blood pressure 
   Median (IQR) 
   < 85 
   ≥ 85 
 
 
118.0 (108-128) 
666 (76.6) 
203 (23.4) 
 
70.0 (64.0-76.0) 
785 (90.3) 
84 (9.7) 
 
 
118.0 (108-130) 
186 (73.5) 
  67 (26.5) 
 
70.0 (64-78.0) 
232 (91.7) 
21 (8.3) 
 
 
118.0 (108-128) 
852 (75.9) 
 270 (24.1) 
 
70.0 (64.0-78.0) 
1017 (90.6) 
105 (9.4) 
 
 
0.53w 
0.31c 
 
 
 
0.63w 
0.51c 
HDL Cholesterol, mg/dl 
   Median (IQR) 
   Low 
   Normal 
 
53.0 (43.0-63.0) 
219 (24.4) 
679 (75.6) 
 
52.0 (43.0-64.0) 
  91 (34.3) 
174 (65.7) 
 
51.0 (42.0-62.0) 
310 (26.7) 
853 (73.3) 
 
  0.87w 
<0.01c 
Triglyceride, mg/dl 
   Median (IQR) 
   High 
   Normal 
 
89.0 (62.0-136.0) 
203 (22.6) 
695 (77.4) 
 
94.0 (67.0-138.0) 
  59 (22.3) 
206 (77.7) 
 
94.0 (64.0-143.0) 
262 (22.5) 
901 (77.5) 
 
0.23w 
0.91c 
Abbreviations: IQR, interquartile range; ARV, antiretroviral. 
c Chi-square statistical test was used to test for association 
w Wilcoxon rank sum test was used to test for median difference 
*P-value highlighted in bold indicate the finding is statistically significant at α=0.05 (p< .05) 
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Table 1.2   Participants Characteristics stratified by Marijuana Use 
 Marijuana Use Total P-value 
 
Demographics 
Current User 
N (%) = 223 (23.8) 
Never User 
N (%) = 714 (76.2) 
 
937 
- 
Age 
Median (IQR) 
   20-35 
   36-55 
    >55 
 
30.0 (24.0-43.0) 
144 (64.6) 
  72 (32.3) 
  7 (3.1) 
 
41.5 (31.0-50.0) 
 237 (33.2) 
 406 (56.9) 
 71 (9.9) 
 
45.0 (33.0-57.0) 
381 (40.7) 
478 (51.0) 
78 (8.3) 
 
<0.01w 
<0.01c 
Gender 
   Female 
   Male 
 
   83 (37.2) 
 140 (62.8) 
 
  427 (59.8) 
  287 (40.2) 
 
  868 (48.6) 
  919 (51.4) 
<0.01c 
Race 
   Hispanic 
   White 
   African- American 
   Other Race/Multi-racial 
 
  33 (14.8) 
104 (46.6) 
  66 (29.6) 
20 (9.0) 
 
232 (32.5) 
218 (30.5) 
110 (15.4) 
154 (21.6) 
 
265 (28.3) 
322 (34.4) 
176 (18.8) 
174 (18.6) 
<0.01c 
 
Education 
   ≤ High School 
   > High School 
 
107 (48.0) 
116 (52.0) 
 
277 (38.8) 
437 (61.2) 
 
 384 (41.0) 
553 (59.0) 
0.02c 
Marital Status 
   Married 
   Others 
 
  49 (22.0) 
174 (78.0) 
 
440 (61.6) 
274 (38.4) 
 
489 (52.2) 
448 (47.8) 
<0.01c 
Poverty to Income Ratio 
Median (IQR) 
   <1.00 
   ≥1.00-4.00 
   >4.00 
 
1.3 (0.69-2.8) 
93 (41.7) 
97 (43.5) 
33 (14.8) 
 
2.3 (1.0-4.3) 
211 (29.6) 
322 (45.0) 
181 (25.4) 
 
2.1 (1.1-4.2) 
304 (32.4) 
419 (44.8) 
214 (22.8) 
 
<0.01 w 
<0.01 C 
 
Physical Activity 
   Active 
   Inactive 
 
109 (48.9) 
114 (51.1) 
 
240 (33.6) 
474 (66.4) 
 
349 (37.2) 
588 (62.8) 
<0.01c 
 
Cigarette Use 
   Current Smoker 
   Past Smoker 
   Non-smoker 
 
126 (56.5) 
  25 (11.2) 
  72 (32.3) 
 
 72 (10.1) 
69 (9.7) 
573 (80.3) 
 
198 (21.2) 
 94 (10.0) 
645 (68.8) 
<0.01c 
 
Clinical Information 
Body waist circumference, cm 
   Median (IQR) 
   Central Obesity 
   Normal  
 
89.6 (80.7-101.3) 
  98 (44.6) 
122 (55.4) 
 
95.5 (84.4-108.0) 
470 (67.1) 
230 (32.9) 
 
95.6 (85.2-107.1) 
568 (61.7) 
352 (38.3) 
 
<0.01w 
Fasting plasma glucose, mg/dl 
   Median (IQR) 
   < 100 
   ≥ 100 
 
95.0 (89.0-101.0) 
151 (70.6) 
63 (29.4) 
 
97.0 (92.0-105) 
408 (58.5) 
289 (41.5) 
 
98.0 (92.0-108.0) 
559 (61.4) 
352 (38.6) 
 
<0.01w 
<0.01c 
Blood Pressure, mmHg, 
   Systolic blood pressure 
   Median (IQR) 
   < 130 
   ≥ 130 
   Diastolic blood pressure 
   Median (IQR) 
   < 85 
   ≥ 85 
 
 
116.0 (108.0-127.0) 
173 (81.6) 
  39 (18.4) 
 
68.0 (60.0-74.0) 
194 (91.5) 
18 (8.5) 
 
 
116.0 (108.0-126) 
540 (81.2) 
125 (18.8) 
 
72.0 (64-78.0) 
599 (90.1) 
66 (9.9) 
 
 
118.0 (108-128) 
713 (81.3) 
164 (18.7) 
 
70.0 (64.0-78.0) 
793 (90.4) 
84 (9.6) 
 
 
0.78w 
0.89c  
 
 
 
<0.01w 
0.54c 
HDL Cholesterol, mg/dl 
   Median (IQR) 
   Low 
   Normal 
 
51.0 (42.0-60.0) 
  54 (25.4) 
159 (74.6) 
 
51.0 (43.0-62.0) 
212 (30.6) 
482 (69.4) 
 
51.0 (42.0-62.0) 
266 (29.3) 
641 (70.7) 
 
0.57w 
0.15c 
Triglyceride, mg/dl 
   Median (IQR) 
   High 
   Normal 
 
86.0 (59.0-135.0) 
  43 (20.2) 
170 (79.8) 
 
94.0 (64.0-141.0) 
162 (23.3) 
532 (76.7) 
 
94.0 (64.0-143.0) 
205 (22.6) 
702 (77.4) 
 
0.16w 
0.49c 
Abbreviations: IQR, interquartile range; ARV, antiretroviral. 
c Chi-square statistical test was used to test for association. 
w Wilcoxon rank sum test was used to test for median difference 
*p-value highlighted in bold indicate the finding is statistically significant at α=0.05 (p< .05) 
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Table 1.3   Participants Characteristics stratified by Metabolic Syndrome 
 Metabolic Syndrome Total P-value 
 
Demographics 
Yes 
N (%) = 629 (29.2) 
No 
N (%) = 1522 (70.8) 
 
2151 
- 
Age 
Median (IQR) 
   20-35 
   36-55 
    >55 
 
51.0 (41.0-61.0) 
107 (17.0) 
271 (43.1) 
251 (39.9) 
 
42.0 (30.0-54.0) 
  543 (35.7) 
  640 (42.0) 
  339 (22.3) 
 
45.0 (33.0-57.0) 
650 (30.2) 
911 (42.4) 
590 (27.4) 
 
<0.01 w 
<0.01c 
Gender 
   Female 
   Male 
 
  332 (52.8)  
 297 (47.2) 
 
783 (51.5) 
739 (48.5) 
 
1115 (51.8) 
1036 (48.2) 
<0.57 
Race 
   Hispanic 
   White 
   African- American 
   Other Race/Multi-racial 
 
175 (27.8) 
262 (41.7) 
124 (19.7) 
  68 (10.8) 
 
331 (21.8) 
614 (40.3) 
314 (20.6) 
263 (17.3) 
 
506 (23.5) 
876 (40.7) 
438 (20.4) 
331 (15.4) 
<0.01c 
 
Education 
   ≤ High School 
   > High School 
 
307 (48.9) 
321 (51.1) 
 
  602 (39.6) 
 919 (60.4) 
 
  909 (42.3) 
1240 (57.7) 
<0.01c 
 
Marital Status 
   Married 
   Others 
 
365 (58.0) 
264 (42.0) 
 
  779 (51.2) 
 743 (48.8) 
 
  1144 (53.2) 
  1007 (46.8) 
<0.01c 
 
Poverty to Income Ratio 
Median (IQR) 
   <1.00 
   ≥1.00-4.00 
   >4.00 
 
1.9 (1.0-3.6) 
194 (30.8) 
 310 (49.3) 
125 (19.9) 
 
2.2 (1.0-4.5) 
446 (29.3) 
663 (43.6) 
413 (27.1) 
 
2.1 (1.0-4.2) 
640 (29.8) 
970 (45.2) 
538 (25.0) 
 
  0.01 w 
<0.01 C 
 
Cigarette Use 
   Current Smoker 
   Past Smoker 
   Non-smoker 
 
159 (25.3) 
158 (25.1) 
312 (49.6) 
 
341 (22.4) 
293 (19.3) 
888 (58.3) 
 
428 (24.0) 
403 (22.5) 
956 (53.5) 
<0.01c 
 
Alcohol Use 
   Current Drinker 
   Nondrinker 
 
221 (24.1) 
  83 (31.4) 
 
696 (75.9) 
181 (68.6) 
 
917 (100.0) 
264 (100.0) 
<0.02c 
 
Marijuana Use 
   Current user 
   Never user 
 
  39 (17.7) 
188 (26.9) 
 
181 (82.3) 
512 (73.1) 
 
220 (100) 
700 (100) 
0.02c 
 
Concurrent Use 
   Yes 
   No 
 
  21 (13.6) 
116 (26.4) 
 
134 (86.4) 
324 (73.6) 
 
155 (100.0) 
440 (100.0) 
0.02c 
Abbreviations: IQR, interquartile range; ARV, antiretroviral. 
c Chi-square statistical test was used to test for association. 
w Wilcoxon rank sum test was used to test for median difference 
*p-value highlighted in bold indicate the finding is statistically significant at α=0.05 (p< .05) 
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Table 2.1: Summary of Stepwise Selection to identify predictors of metabolic syndrome with Alcohol 
Use as main independent variable 
 
Step 
Effect  
DF 
Number 
In 
Score ChiSq Pr > ChiSq 
 Entered Removed 
 Alcohol  1 5 2.40 0.12 
 Age Group  1 1 54.49 <0.01 
 Race  1 2 9.35 <0.01 
 Education  1 3 3.93 0.05 
 Marital status  1 4 2.69 0.10 
 Cigarette smoking  1 6 2.60 0.16 
 
Table 2.2:  Summary of Stepwise Selection to identify predictors of metabolic syndrome with 
Marijuana Use as main independent variable 
 
Step 
Effect  
DF 
Number 
In 
Score ChiSq Pr > ChiSq 
 Entered Removed 
 Marijuana   1 6 2.87 0.09 
 Age Group  1 1 35.9 <0.01 
 Race  1 2 14.10 <0.01 
 Poverty  1 3 2.52 0.11 
 Marital status  1 4 2.41 0.12 
 Cigarette smoking  1 5 1.18 0.28 
 
Table 2.3: Summary of Stepwise Selection to identify predictors of metabolic syndrome with 
Concurrent Use as main independent variable 
 
Step 
Effect  
DF 
Number 
In 
Score ChiSq Pr > ChiSq 
 Entered Removed 
 Concurrent Use  1 3 2.98 0.08 
 Age Group  1 1 31.06 <0.01 
 Race  1 2 8.12 <0.01 
 Cigarette smoking  1 4 2.21 0.14 
 Poverty  1 5 1.09 0.30 
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Table 3.1: Unadjusted Odds ratio for metabolic Syndrome stratified by alcohol, marijuana, and concurrent use 
 
  
 
Participant Characteristics 
 
Crude OR (95% CI)  
Alcohol Use 
   Non-drinkera 
   Current drinker 
 
1.00 
0.69 (0.51, 0.94) 
Current Drinking Level 
    Non-drinkera 
   Low/Moderate drinker 
   Heavy drinker 
 
1.00 
0.70 (0.49, 0.99) 
0.82 (0.53, 1.25) 
Marijuana Use 
   Never usera 
   Current user 
 
1.00 
0.59 (0.40, 0.86) 
Concurrent Use 
   Noa 
   Yes 
 
1.00 
0.44 (0.26, 0.73) 
Abbreviations: OR, Odds ratio; CI, confidence Interval 
a; reference category for alcohol/marijuana/concurrent use/current drinking level 
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Table 3.2: Multivariable adjusted OR for metabolic Syndrome stratified by alcohol, marijuana, and concurrent use 
 Participant Characteristics  Adjusted OR (95%)* 
Current drinkera (Model 1)  0.69 (0.49, 0.99) 
Hispanicb   1.53 (1.06, 2.21) 
African American  1.05 (0.72, 1.54) 
Other/Multi-racial  0.77 (0.50, 1.20) 
36-55 Yearsc  2.57 (1.80, 3.68) 
>55 Years  3.36 (2.26, 4.99) 
PIR (1.00 – 4.00)d  1.12 (0.79, 1.58) 
PIR (> 4.00)  0.88 (0.57, 1.35) 
Current smokere   1.20 (0.82, 1.76) 
Past smoker  1.72 (1.19, 2.48) 
Marriedf  1.26 (0.93, 1.69) 
≤High Schoolg   1.18 (0.87, 1.76) 
Current marijuana usera (Model 2)  0.62 (0.38, 1.01) 
Hispanicb  1.11 (0.73, 1.67) 
African American  0.82 (0.52, 1.30) 
Other/Multi-racial  0.48 (0.29, 0.80) 
36-55 Yearsc  2.26 (1.55, 3.29) 
>55 Years  3.65 (2.06, 6.45) 
PIR (1.00 – 4.00)d  0.96 (0.67, 1.38) 
PIR (> 4.00)  0.68 (0.41, 1.12) 
Current smokere   1.53 (0.97, 2.43) 
Past smoker  0.74 (0.42, 1.31) 
Marriedf  1.27 (0.90, 1.80) 
≤High Schoolg  1.04 (0.73, 1.48) 
Concurrent Usea (Model 3)  0.53 (0.28, 0.99)** 
Hispanicb  1.34 (0.79, 2.27) 
African American  0.83 (0.47, 1.47) 
Other/Multi-racial  0.64 (0.34, 12.0)  
36-55 Yearsc  2.95 (1.85, 4.68) 
>55 Years  4.00 (1.98, 8.05) 
Current smokere  1.50 (0.83, 2.72) 
Past Smoker  0.93 (0.45, 1.94) 
≤High Schoolg  1.15 (0.75, 1.77) 
Abbreviations: OR, Odds ratio; CI, confidence Interval; PIR, Family Income to Poverty Ratio 
*Adjusted model for alcohol and marijuana use included the following covariates: Age, Race, Educational Level, Marital Status, 
Poverty, and Cigarette Smoking status. 
**Adjusted model included the following covariates: Age, Race, Educational level, Cigarette smoking status. 
a; reference category for alcohol/marijuana/concurrent use—nondrinker/never user/non-concurrent user, 
b; reference category for race—Whites  
c; reference category for age group—age group 20-35 years 
d; reference category for family to income ratio—PIR < 1.00 
e; reference category cigarette smoking—never smoker 
f; reference category for marital status—others 
g; reference category for level of education—> High school 
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